Contributors

Alexander Rich elucidated the double helix structure of RNA 50 years ago. "The puzzle came straight out of the Watson and Crick paper," says Rich. "There's a statement in there that says it is probably impossible to form this structure with ribose rather than deoxyribose." On page 34, Rich describes that discovery, as well as what's next for the field of RNAi and others related to his findings. Rich earned an MD from Harvard in 1949 and went on spend five years at CalTech worki

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Alexander Rich elucidated the double helix structure of RNA 50 years ago. "The puzzle came straight out of the Watson and Crick paper," says Rich. "There's a statement in there that says it is probably impossible to form this structure with ribose rather than deoxyribose." On page 34, Rich describes that discovery, as well as what's next for the field of RNAi and others related to his findings. Rich earned an MD from Harvard in 1949 and went on spend five years at CalTech working with Linus Pauling. He continued to study nucleic acids at MIT, where his lab remains today.

Staff writer Kerry Grens joined The Scientist in September after two years as the health and science reporter for New Hampshire Public Radio. Before that, she earned a master's degree in biology from Stanford. On page 18, she writes about why researchers have attached condoms to robotic frogs to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies